KD comparison from ITC, SPR, and ELISA assays.
| Sample | KD (nM) ITC | KD (nM) SPR | KD (nM) ELISA |
|---|---|---|---|
| Bevacizumab | 2.3 | 1.33 | 0.08 |
| Fabbeva | 13.9 | 4.2 | 0.32 |
| FpFbeva | 2.1 | 1.54 | 0.11 |
| Sample | KD (nM) ITC | KD (nM) SPR | KD (nM) ELISA |
|---|---|---|---|
| Bevacizumab | 2.3 | 1.33 | 0.08 |
| Fabbeva | 13.9 | 4.2 | 0.32 |
| FpFbeva | 2.1 | 1.54 | 0.11 |